RIO DE JANEIRO, BRAZIL - Treatment with anticoagulants can improve the survival time of critically ill patients infected with the novel coronavirus, according to a new observational study by experts at Mount Sinai Hospital in New York. The research shows that drugs of this type can work as a treatment for the disease, rather than as prevention.
The researchers noted that patients treated with anticoagulants showed significant improvement in their conditions.
"Research shows that oral, subcutaneous, or intravenous anticoagulants have played a major role in treating patients with Covid-19 and can prevent fatal events associated with coronavirus, such as heart . . .